Anal cancer screening for gay and bisexual men on PrEP
Part of Cancer, Digestive system clinical trials.
This study is screening gay and bisexual men for anal cancer by taking a swab sample. It aims to find early signs of cancer so it can be treated early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man who has sex with men (gay or bisexual).
- You are 35 years old or older.
- You have been taking PrEP (HIV prevention pills) for at least 3 months.
- You can speak and write Dutch, English, or French.
- You have not had any anal procedures or treatments in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to screen for HPV, a virus linked to anal cancer. People living with HIV will either collect their own sample or have a doctor do it, then switch methods. The goal is to see which is more comfortable and accurate.
This study tests a self-collected anal swab for detecting HPV (the virus that can cause anal cancer) in people living with HIV. It aims to see if this simple swab is as accurate as a doctor-collected sample, and may help prevent anal cancer.
This study tests whether having people collect their own anal samples at home can help find and treat early signs of anal cancer. It is for men and transgender women who have sex with men and who live in or near Chicago, Houston, or Milwaukee.
This study is testing a new way to screen for anal cancer by looking at DNA methylation in cells collected from the anus. It may help people at higher risk for anal cancer find out earlier if they need further tests.
This study tests how well a special HPV test (called BD Onclarity™) can find anal cancer or precancer. It is for people at high risk or with known anal abnormalities, and aims to improve early detection.
This study looks at HPV (the virus that can cause anal cancer) and checks if certain types of high-risk HPV are linked to abnormal cells or cancer in the anus, 10 years after joining the IPERGAY trial. It helps researchers understand long-term risks.
Hear when a new Anal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.